Genetic Engineering and Society Jennifer Kuzma

Goodnight-NC GSK Foundation Distinguished Professor/Co-Director GES Center

image of jennifer kuzma

Contact Information

James B Hunt Jr Centennial Cam 5147
Raleigh, NC
P: 919-515-2592

Jennifer Kuzma is a Chancellor’s Faculty Excellence Program cluster hire in Genetic Engineering and Society. Kuzma is the Goodnight-North Carolina GlaxoSmithKline Foundation Distinguished Professor in Social Sciences in the School of Public and International Affairs (SPIA) and co-director of the Genetic Engineering and Society (GES) Center at NC State. She advises students and teaches in SPIA, the GES graduate minor, and the National Science Foundation Integrative Graduate Education and Research Traineeship program in genetic pest management. Kuzma co-founded the GES center, as well as designed and developed several of its programs and activities. The GES center maintains external partnerships locally, nationally and globally, and has led several research, education and engagement initiatives that improve dialogue and decision making about the applications of genetic engineering.

Previously, Kuzma was a faculty member in science and technology policy at the University of Minnesota Humphrey School of Public Affairs; study director for genetic engineering and bioterrorism at the National Academies of Science; and an American Association for the Advancement of Science Risk Policy Fellow at the Department of Agriculture. Since arriving at NC State, she has received several grants for her research, including an Alfred P. Sloan Foundation Grant for work on synthetic biology and risk-governance policy processes and tools; an NSF grant for an international, deliberative workshop on gene-drive technologies and the ecological and societal aspects of their application to pest and disease management; and an NSF research grant for exploring meanings of responsible innovation in different communities and organizations involved in genetic engineering debates.

Kuzma has more than 100 scholarly publications on emerging technologies and governance. She serves on the National Academy of Sciences (NAS) Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System and on the Council on Agricultural Science and Technology CAST Committee on Gene Editing. She has served as secretary of the Society for Risk Analysis Council, chair of the Gordon Conference on Science and Technology Policy, the FDA Blood Products Advisory Committee, and the U.N. World Health Organization-Food and Agriculture Organization Expert Group for Nanotechnologies in Food and Agriculture. In 2014, she received the Society for Risk Analysis Sigma Xi Distinguished Lecturer Award in recognition of her outstanding contributions to the field of risk analysis. She has been called upon in national media, including the Washington Post, Scientific American, New York Times, Nature and NPR, for her expertise on genetic engineering policy issues.